Apple Watch Hypertension Notifications receive FDA Clearance, Launching ⁤Next Week

Apple's recently announced hypertension notifications for teh Apple Watch have received clearance from the Food and Drug Administration (FDA) in the United States. The feature, unveiled alongside⁢ the Apple Watch Series 11 and Apple Watch Ultra 3 ⁢this week, is slated to become available next week, as Apple initially anticipated.

The hypertension notifications will be available in over 150 countries and regions globally at launch, encompassing the United States, European Union member states, Hong Kong, and New Zealand. This broad availability underscores Apple's commitment to expanding access to preventative health technologies.

The feature⁢ will be compatible with the new apple Watch Series 11 and Apple Watch Ultra 3,and also the ⁤Apple Watch Series 9,Apple Watch Series 10,and Apple Watch Ultra 2. This ensures a⁤ wide⁣ range ⁢of users can benefit from the new health monitoring capability.

Apple describes the feature as follows:

[[[[Original quote from Apple would go here. The provided text ends abruptly. This needs to⁣ be ⁤completed with the full quote.]

Hypertension, commonly known as high blood pressure, affects approximately 116.4 million adults ⁢in the United States, according to the Centers for Disease Control and Prevention (CDC) data from 2021-2022.It is indeed a major⁣ risk factor for heart disease, stroke, and kidney failure. Early detection and management are critical for mitigating these risks.